You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

Citation Tools

Article menu

Download PDFPDF

Friday 07 October 2022 from 13:00 to 14:10
Po.6 E- poster session 6: management and recommendations, old and new therapies/biologics
PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tchao N, Sarkar N, Hu X, et al
PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study
Lupus Science & Medicine 2022;9:doi: 10.1136/lupus-2022-elm2022.148